Twist Bioscience: DNA on Chips! Revenue Record and AWS Deal Could Lead to Breakthrough!
Reading Time: 3 minutes
Finally, a final deal between the USA and Iran is expected to be signed by the end of this week. Oil prices are declining significantly. The "Healthcare" sector still holds the top position in our rankings. We want to take a closer look at Twist Bioscience. The stock has surged nearly 44% in just one month. Which area of diagnostics is the company focused on? We'll find out. Twist Bioscience writes artificial DNA on silicon chips AI-driven drug discovery in partnership with Amazon Bio Discovery 13th consecutive quarter of growth at $110.7...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
